Compare Mutual Funds

Pros
Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons
3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
8/9
9/9
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

10 Years 11 Months

13 Years 11 Months

Fund AUM

₹1565 Cr

₹9479 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

1%

0.99%

Exit Load

0.25%

1%

Benchmark Index

Nifty Pharma TR INR

BSE Healthcare TR INR

No of Holdings

39

38

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(8.59%)
  2. Divi's Laboratories Ltd(6.36%)
  3. HealthCare Global Enterprises Ltd(5.85%)
  4. Abbott India Ltd(5.63%)
  5. Rainbow Childrens Medicare Ltd(4.9%)
  1. Sun Pharmaceuticals Industries Ltd(13.31%)
  2. Lupin Ltd(7.25%)
  3. Divi's Laboratories Ltd(6.52%)
  4. Cipla Ltd(6.03%)
  5. Apollo Hospitals Enterprise Ltd(5.3%)
No of Sectors

3

1

Top 3 Sectors
  1. Health(92.97%)
  2. Basic Materials(5.87%)
  3. Consumer Defensive(1.16%)

Health

(100%)

Equity %

99.14%

97.32%

Debt %

-

-

P/E

40.58

39.2

P/B

6.28

5.82

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

-4.29%

-2.96%

3-Month Return

-0.15%

0.79%

6-Month Return

15.2%

14.88%

1-Year Return

7.91%

12.36%

3-Year Return

18.26%

17.62%

5-Year Return

14.01%

13.51%

Sharpe

0.74

0.76

Alpha

-1.52

-1.58

Beta

1

0.89

Standard Deviation

16.74

15.07

Information Ratio

-0.45

-0.9

Description

Tata India Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Rajat Srivastava

Sailesh Raj Bhan, Kinjal Desai, Amber Singhania

Most Popular Comparisons